ABCL News and Press, AbCellera Biologics Inc. From 03/10/21

The tech selloff so far has been brutal and quick, with 5% to 10% moves daily in high growth names across the board. On February 23rd I published a list of my picks to buy on weakness and I acted on it, in some cases it appears too early. Below I list which companies I purchased d...

AbCellera ([[ABCL]] +6.0%) announces that bamlanivimab (LY-CoV555) 700 mg, a human antibody discovered by AbCellera and developed with Eli Lilly (LLY), and etesevimab 1400 mg (LY-CoV16) together reduced COVID-19-related hospitalizations and deaths by 87% in high-risk patients recently di...

Patients who received bamlanivimab and etesevimab together had an 87% reduction in hospitalizations and death; no patients died who received the therapy AbCellera (Nasdaq: ABCL) today announced that bamlanivimab (LY-CoV555) 700 mg, a human antibody discovered by AbCeller...

AbCellera Biologics is a little followed and largely uncovered company. What it is building however is known all throughout the biotech and pharma industries. With the likes of Bill Gates, Peter Thiel and DARPA as key backers, AbCellera is quietly creating a call option on vast swaths...

Gainers: [[SNSE]] +17.5%. [[ABCL]] +8.3%. [[AGLE]] +7.6%. [[OLED]] +5.9%. [[EOLS]] +5.4%.Losers: [[CRWD]] -7.0%. [[ARDX]] -6.9%. [[NK]] -6.6%. [[CATB]] -3.2%. [[ISEE]] -3.1%. For further details see: SNSE, AGLE, CRWD and ISEE among after-hours movers

AbCellera ([[ABCL]] -6.1%) announced that the European Medicines Agency's ((EMA)) Committee for Medicinal Products for Human Use ((CHMP)) has issued a positive recommendation for bamlanivimab alone and in combination with etesevimab for the treatment of confirmed COVID-19 in certain...

Positive European Union (EU)-level scientific opinion provides a pathway for more EU countries to access the antibodies to treat COVID-19 before formal marketing authorizations are granted AbCellera (Nasdaq: ABCL) today announced that the European Medicines Agency's (EMA) Co...

Gainers: Five Prime Therapeutics (FPRX) +78%, Ampio Pharmaceuticals (AMPE) +10%, Soligenix (SNGX) +7%.Losers: BioVie (BIVI) -29%, Schrodinger (SDGR) -25%, KemPharm (KMPH) -19%, Anchiano Therapeutics (ANCN) -15%, AbCellera Biologics (...

AbCellera (NASDAQ: ABCL) will present at the 10th Annual SVB Leerink Global Healthcare Conference on Thursday, February 25, 2021 at 1:20 p.m. Pacific Time. A live audio webcast may be accessed through a link that will be posted on AbCellera’s Investor Relations website ...

Viking Global (Andreas Halvorsen) added new positions in General Electric (GE), AbCellera Biologics (ABCL), The Walt Disney (DIS) and UnitedHealth (UNH), latest 13F filing indicates.Notable increases: Boston Scientific (BSX), Visa (V), Microsoft (MSFT), and Otis Worldwide (OTIS).The...